• Explore /
  • Poster
  • / Incidence and costs associated with clinically significant events in real-world patients with unresectable hepatocellular carcinoma on systemic therapy.

Incidence and costs associated with clinically significant events in real-world patients with unresectable hepatocellular carcinoma on systemic therapy.

Abstract Poster

Authors

Marcus Healey, I

Marcus Healey

AstraZeneca, Gaithersburg, MD;

Marcus Healey , Daniel Simmons , Stephen J Valerio , Janvi Sah , Debra Pierce , Zhuoxin Jiang , Darren Thomas , Jesica Levingston Mac Leod , Yian Lin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 514)

DOI

10.1200/JCO.2023.41.4_suppl.514

Abstract #

514

Poster Bd #

B4

Abstract Disclosures

Similar Posters

First Author: David Edward Kaplan

First Author: Masafumi Ikeda

First Author: Arndt Vogel

First Author: David Edward Kaplan